HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma

Overview of attention for article published in Clinical Cancer Research, February 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Dimensions has found 121 publications that cite this research output.

Article in Proceedings of the National Academy of Sciences of the United States of America (April 2024)

Article in American Journal of Ophthalmology Case Reports (February 2024)

Article in BJC Reports (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.